Angelika M Vollmar Selected Research

Angelika M Vollmar Research Topics

Disease

52	Neoplasms (Cancer) 01/2022 - 02/2004
9	Reperfusion Injury 10/2009 - 01/2002
8	Neoplasm Metastasis (Metastasis) 01/2018 - 09/2010
8	Ischemia 10/2009 - 01/2002
6	Breast Neoplasms (Breast Cancer) 07/2015 - 10/2009
6	Inflammation (Inflammations) 10/2011 - 04/2003
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 07/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 03/2007 - 10/2002
3	Leukemia 01/2021 - 12/2003
3	Carcinoma (Carcinomatosis) 01/2019 - 09/2010
3	Hypoxia (Hypoxemia) 05/2016 - 03/2011
3	Heart Failure 01/2012 - 01/2007
3	Hepatitis 02/2011 - 02/2003
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 02/2004
2	Tics (Tic) 11/2017 - 03/2017
2	Edema (Dropsy) 10/2012 - 08/2006
2	Necrosis 07/2011 - 09/2003
2	Hyperplasia 08/2010 - 06/2009
2	Hypertrophy 07/2005 - 10/2002
2	Atherosclerosis 02/2004 - 09/2002
2	Liver Diseases (Liver Disease) 09/2003 - 04/2003
1	Melanoma (Melanoma, Malignant) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	Leukemia L1210 01/2019
1	Blister (Bulla) 12/2016
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2015
1	Ataxia Telangiectasia (Louis Bar Syndrome) 07/2015

Drug/Important Bio-Agent (IBA)

11	Adenosine Triphosphatases (ATPase)IBA 01/2019 - 11/2012
10	Pharmaceutical PreparationsIBA 01/2019 - 01/2007
9	Atrial Natriuretic Factor (ANF)IBA 01/2007 - 01/2002
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2009
5	TubulinIBA 01/2019 - 01/2012
4	CationsIBA 01/2022 - 01/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2004
4	pretubulysinIBA 01/2019 - 01/2012
4	Phosphotransferases (Kinase)IBA 07/2015 - 08/2009
4	Concanavalin AIBA 10/2011 - 11/2002
3	Biological ProductsIBA 05/2020 - 10/2009
3	Cyclin-Dependent Kinase 5IBA 01/2019 - 07/2015
3	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 07/2015 - 01/2013
3	Proton Pumps (Proton Pump)IBA 04/2014 - 11/2012
3	p38 Mitogen-Activated Protein KinasesIBA 03/2011 - 08/2002
3	NF-kappa B (NF-kB)IBA 10/2009 - 02/2004
3	cephalostatin IIBA 03/2008 - 12/2003
2	Two-Pore ChannelsIBA 01/2021 - 01/2017
2	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 01/2019
2	LipidsIBA 01/2018 - 02/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 02/2016
2	Transcription Factors (Transcription Factor)IBA 05/2016 - 02/2004
2	doliculideIBA 01/2016 - 09/2014
2	indirubinIBA 09/2014 - 10/2013
2	Protein Kinases (Protein Kinase)IBA 10/2013 - 11/2007
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2011 - 02/2003
2	RoscovitineIBA 09/2011 - 07/2011
2	Heme Oxygenase-1IBA 03/2011 - 04/2003
2	Propolis (Bee Bread)IBA 03/2011 - 08/2006
2	PolyphenolsIBA 08/2010 - 09/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 02/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2007 - 02/2005
2	ResveratrolIBA 07/2005 - 10/2002
2	Angiotensin IIIBA 07/2005 - 10/2002
2	Krebs-Henseleit solutionIBA 10/2003 - 09/2003
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 09/2003 - 01/2002
2	Messenger RNA (mRNA)IBA 04/2003 - 01/2002
1	Cadherins (E-Cadherin)IBA 01/2022
1	Melanins (Melanin)IBA 01/2021
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2021
1	tetrandrineIBA 01/2021
1	FlavonoidsIBA 01/2021
1	Cytostatic AgentsIBA 01/2021
1	EnzymesIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	ProteomeIBA 01/2020
1	Tigecycline (Tygacil)FDA Link 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2019
1	neocarzilin AIBA 07/2019
1	AntimetabolitesIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	chondramide BIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	IntegrinsIBA 01/2018
1	archazolid AIBA 11/2017
1	LDL CholesterolIBA 10/2017
1	Cholera ToxinIBA 10/2017
1	Bacterial ToxinsIBA 10/2017
1	CholesterolIBA 02/2017
1	Topoisomerase InhibitorsIBA 01/2017
1	NAADP (nicotinic acid adenine dinucleotide phosphate)IBA 01/2017
1	HydrogelsIBA 12/2016
1	CollagenIBA 12/2016
1	matrigelIBA 12/2016
1	Fibrillar CollagensIBA 12/2016
1	Lipid Bilayers (Lipid Bilayer)IBA 11/2015
1	Lipid NanoparticlesIBA 11/2015
1	IronIBA 07/2015
1	Therapeutic UsesIBA 07/2015

Therapy/Procedure

19	Therapeutics 01/2021 - 09/2011
3	Drug Therapy (Chemotherapy) 01/2021 - 09/2011
2	Immunotherapy 05/2020 - 06/2009